It has already been described that patients treated with anti-TNFα exhibited lower serologic responses one month and six months after vaccination (COVID-19 BNT162b2) compared to those not treated with anti-TNFα or to healthy controls (HCs) [44]. Here, TNF is linked to COVID-19.